Evaluation of the Impact of Physical Reconditioning Associated With Specific Nutritional Supplementation in Obese Patients Suffering of Metabolic Syndrome. OBEFITT Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Arginine (Primary) ; Leucine (Primary)
- Indications Metabolic syndrome; Obesity
- Focus Biomarker; Therapeutic Use
- Acronyms OBEFITT
- 25 Jan 2016 Biomarkers information updated
- 15 Apr 2013 Planned number of patients changed from 80 to 100 as reported by ClinicalTrials.gov.
- 20 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.